This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003 Jun;11(2):79-82.

doi: 10.1076/ocii.11.2.79.15918.

Methotrexate in inflammatory eye disease

Richard Stawell

PMID: 14533026
DOI: 10.1076/ocii.11.2.79.15918

Review

Methotrexate in inflammatory eye disease

Richard Stawell. Ocul Immunol Inflamm. 2003 Jun.

. 2003 Jun;11(2):79-82.

doi: 10.1076/ocii.11.2.79.15918.

Author

Richard Stawell

PMID: 14533026
DOI: 10.1076/ocii.11.2.79.15918

No abstract available

PubMed Disclaimer

Comment on

Methotrexate as a first-line corticosteroid-sparing therapy in a cohort of uveitis and scleritis.
Kaplan-Messas A, Barkana Y, Avni I, Neumann R. Kaplan-Messas A, et al. Ocul Immunol Inflamm. 2003 Jun;11(2):131-9. doi: 10.1076/ocii.11.2.131.15919. Ocul Immunol Inflamm. 2003. PMID: 14533032

Similar articles

Retention time for corticosteroid-sparing systemic immunosuppressive agents in patients with inflammatory eye disease.
Baker KB, Spurrier NJ, Watkins AS, Smith JR, Rosenbaum JT. Baker KB, et al. Br J Ophthalmol. 2006 Dec;90(12):1481-5. doi: 10.1136/bjo.2006.097998. Epub 2006 Aug 16. Br J Ophthalmol. 2006. PMID: 16914474 Free PMC article.
Intravitreal methotrexate in uveitis.
Taylor SR, Habot-Wilner Z, Pacheco P, Lightman S. Taylor SR, et al. Ophthalmology. 2012 Apr;119(4):878-9. doi: 10.1016/j.ophtha.2011.12.015. Ophthalmology. 2012. PMID: 22472251 No abstract available.
[Immunosuppressive therapy in intraocular inflammation. II. Basic principles, indications, contraindications, side-effects].
Manthey KF. Manthey KF. Ophthalmologe. 1998 Dec;95(12):846-58. doi: 10.1007/s003470050365. Ophthalmologe. 1998. PMID: 10025150 Review. German. No abstract available.
Methotrexate and chronic uveitis associated with juvenile idiopathic arthritis.
Chan AY, Liu DT. Chan AY, et al. J Rheumatol. 2006 Jan;33(1):198; author reply 198. J Rheumatol. 2006. PMID: 16395772 No abstract available.
Immunosuppressive drugs in immune and inflammatory ocular disease.
Hemady R, Tauber J, Foster CS. Hemady R, et al. Surv Ophthalmol. 1991 Mar-Apr;35(5):369-85. doi: 10.1016/0039-6257(91)90186-j. Surv Ophthalmol. 1991. PMID: 2038720 Review.

See all similar articles

Cited by

Laponite for biomedical applications: An ophthalmological perspective.
Rodrigo MJ, Cardiel MJ, Fraile JM, Mayoral JA, Pablo LE, Garcia-Martin E. Rodrigo MJ, et al. Mater Today Bio. 2023 Dec 28;24:100935. doi: 10.1016/j.mtbio.2023.100935. eCollection 2024 Feb. Mater Today Bio. 2023. PMID: 38239894 Free PMC article. Review.
Challenges with cataract surgery in pars planitis patients.
Grzybowski A, Kanclerz P, Pleyer U. Grzybowski A, et al. Graefes Arch Clin Exp Ophthalmol. 2017 Aug;255(8):1483-1484. doi: 10.1007/s00417-017-3698-6. Epub 2017 Jun 7. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 28593425 Free PMC article. No abstract available.
Anticancer agents against malaria: time to revisit?
Nzila A, Okombo J, Becker RP, Chilengi R, Lang T, Niehues T. Nzila A, et al. Trends Parasitol. 2010 Mar;26(3):125-9. doi: 10.1016/j.pt.2009.12.002. Epub 2010 Jan 6. Trends Parasitol. 2010. PMID: 20056487 Free PMC article.
A phase I trial to evaluate the safety and pharmacokinetics of low-dose methotrexate as an anti-malarial drug in Kenyan adult healthy volunteers.
Chilengi R, Juma R, Abdallah AM, Bashraheil M, Lodenyo H, Nyakundi P, Anabwani E, Salim A, Mwambingu G, Wenwa E, Jemutai J, Kipkeu C, Oyoo GO, Muchohi SN, Kokwaro G, Niehues T, Lang T, Nzila A. Chilengi R, et al. Malar J. 2011 Mar 16;10:63. doi: 10.1186/1475-2875-10-63. Malar J. 2011. PMID: 21410944 Free PMC article. Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon